Ruxolitinib and methylprednisolone for treatment of patients with relapsed/refractory multiple myelomaJames R. Berenson, Robert Vescio, Benjamin Eades et al.|British Journal of Haematology|2022Cited by 12
Efficacy and Safety of Ruxolitinib and Steroids for Treating Patients with Relapsed or Refractory Multiple Myeloma (RRMM)James R. Berenson, Robert Vescio, Noemi Silagan et al.|Blood|2020Cited by 2
A Phase 1 Trial of Ruxolitinib, Lenalidomide and Methylprednisolone for Patients with Relapsed/Refractory Multiple Myeloma (MM)James R. Berenson, Robert Vescio, Jennifer To et al.|Blood|2019Cited by 2
Ruxolitinib and Methylprednisolone for Treatment of Patients with Relapsed/Refractory Multiple MyelomaJames R. Berenson, Robert Vescio, Daisy Martinez et al.|Blood|2022Cited by 2
Efficacy and Safety of Ruxolitinib and Steroids for Treating Patients with Relapsed or Refractory Multiple MyelomaJames R. Berenson, Robert Vescio, Daisy Martinez et al.|Blood|2021Cited by 1